2007 - 2019 KAS Herlev, Radiologisk afd X, overlæge
2007 - 2007 KAS Herlev, Radiologisk afd X, (konst. overlæge)
2006 - 2006 KAS Herlev, Radiologisk afd X, (afdelingslæge)
2005 - 2006 Hvidovre Hospital (afdelingslæge)
2004 - 2005 Roskilde Sygehus
2003 - 2004 Køge Sygehus
2002 - 2003 Rigshospitalet
2001 - 2002 Hvidovre Hospital
2001 - 2001 Bispebjerg Hospital
2000 - 2001 Radiologisk Afd., KAS Glostrup
1999 - 2000 Radiologisk Afd, KAS Glostrup
1982 Studentereksamen
1988 Medicinsk kandidat på Akademia Medyczna i Warszawa.
Kirurgisk Afdeling, Szpital Srodmiejski i Warszawa
Børnekirurgisk Afdeling, Szpital Kopernika i Warszawa
Kirurgisk Afdeling, Frederikshavn Sygehus (uklassificeret)
Kir. Gastroenterologisk Afd., Rigshospitalet (introduktion)
Publikationer
Szkudlarek J., Elsborg L. Treatment of severe obesity with a highly selective serotonin reuptake inhibitor as a supplement to a low caloric diet. Int J Obesity, 1993; 17: 681-683.
Szkudlarek J., Jeppesen PB, Brøbech PB. Treatment of severe short bowel syndrome with high dose growth hormone and glutamine. (abstract). Gastroenterology, 1998; 114: 699a.
Szkudlarek J, Heydorn, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone and glutamine on intestinal absorption and body composition in short bowel syndrome. A randomized, double blind, cross-over, placebo-controlled study. (abstract). Gastroenterology, 1999; 116: 580a.
Szkudlarek J, Jeppesen PB, Brøbech. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut. 2000 Aug;47(2):199-205.
Jeppesen PB, Szkudlarek J, Høy C.E., Mortensen PB. Effect of High-Dose Growth Hormone and Glutamine on Body Composition, Urine Creatinine Excretion, Fatty Acid Absorption, and Essential Fatty Acids Status in Short Bowel Patients. A Randomized, Double-blind, Crossover, Placebo-controlled Study. Cand J Gastroenterol 2001;36;48-54.
Szkudlarek J., Elsborg L. Treatment of severe obesity with a highly selective serotonin reuptake inhibitor as a supplement to a low caloric diet. Int J Obesity, 1993; 17: 681-683.
Szkudlarek J., Jeppesen PB, Brøbech PB. Treatment of severe short bowel syndrome with high dose growth hormone and glutamine. (abstract). Gastroenterology, 1998; 114: 699a.
Szkudlarek J, Heydorn, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone and glutamine on intestinal absorption and body composition in short bowel syndrome. A randomized, double blind, cross-over, placebo-controlled study. (abstract). Gastroenterology, 1999; 116: 580a.
Szkudlarek J, Jeppesen PB, Brøbech. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut. 2000 Aug;47(2):199-205.
Jeppesen PB, Szkudlarek J, Høy C.E., Mortensen PB. Effect of High-Dose Growth Hormone and Glutamine on Body Composition, Urine Creatinine Excretion, Fatty Acid Absorption, and Essential Fatty Acids Status in Short Bowel Patients. A Randomized, Double-blind, Crossover, Placebo-controlled Study. Cand J Gastroenterol 2001;36;48-54.
